Chemoinformaics analysis of [(E)-HEX-2-ENYL] HEXANOATE
| Molecular Weight | 198.306 | nRot | 8 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 2 |
| Exact Molecular Weight | 198.162 | nRing | 0 |
| Solubility: LogS | -1.378 | nHRing | 0 |
| Solubility: LogP | 1.677 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 36.3134 |
| nHD | 0 | BPOL | 24.6746 |
| QED | 0.416 |
| Synth | 2.281 |
| Natural Product Likeliness | 1.575 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.176 |
| MDCK | 0.0000283 |
| BBB | 0.731 |
| PPB | 0.648257 |
| VDSS | 1.22 |
| FU | 0.47226 |
| CYP1A2-inh | 0.959 |
| CYP1A2-sub | 0.931 |
| CYP2c19-inh | 0.773 |
| CYP2c19-sub | 0.809 |
| CYP2c9-inh | 0.236 |
| CYP2c9-sub | 0.262 |
| CYP2d6-inh | 0.18 |
| CYP2d6-sub | 0.234 |
| CYP3a4-inh | 0.058 |
| CYP3a4-sub | 0.315 |
| CL | 9.48 |
| T12 | 0.794 |
| hERG | 0.021 |
| Ames | 0.015 |
| ROA | 0.02 |
| SkinSen | 0.722 |
| Carcinogencity | 0.134 |
| EI | 0.992 |
| Respiratory | 0.26 |
| NR-Aromatase | 0.01 |
| Antiviral | Yes |
| Prediction | 0.594668 |